CLINICAL_TRIALS
trial_result
· 2023-07-05
Clinical Trial Update: Phase 2 of HU-045 in Glabellar Lines [Phase 2]
Summary
Phase 2 trial of HU-045 in glabellar lines completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Huons Co., Ltd. | Conditions: Glabellar Lines | Phase 2 | Status: COMPLETED